The European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS) applied to pivotal phase III randomized-controlled trials of tyrosine kinase inhibitors in first-line for advanced non-small cell lung cancer with activating e
| Image |  |
|---|---|
| Description | scientific article published on 10 November 2016 |
| Author/s |
author: Jacopo Giuliani Andrea Bonetti Andrea Remo |
| Publication date | November 21, 2016 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |